Related Experiment Video
Updated: Jun 16, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Update on recent developments in the therapy of differentiated thyroid cancer
Marcus Middendorp1, Frank Grünwald
1Department of Nuclear Medicine, Johann Wolfgang Goethe University, Frankfurt/Main, Germany.
Seminars in Nuclear Medicine
|February 2, 2010
Summary
Management of differentiated thyroid carcinoma has advanced, improving patient outcomes. Key developments include individualized surgery, refined radioiodine therapy, and new treatments like tyrosine kinase inhibitors for advanced cases.
Area of Science:
- Oncology
- Endocrinology
Background:
- Differentiated thyroid carcinoma (DTC) management has evolved significantly over the last decade.
- Improvements in surgical techniques and therapeutic strategies have enhanced the favorable prognosis of DTC.
Purpose of the Study:
- To review current optimal therapy regimens for differentiated thyroid carcinoma.
- To discuss advancements in surgical, radioiodine, and novel therapeutic approaches for DTC management.
Main Methods:
- Review of current literature and clinical guidelines on DTC management.
- Discussion of established and emerging treatment modalities including surgery, radioiodine therapy, recombinant human thyroid-stimulating hormone (rhTSH) use, and tyrosine kinase inhibitors.
Main Results:
- Surgical treatment is increasingly individualized.
- Radioiodine therapy remains crucial, with rhTSH facilitating remnant ablation and follow-up.
- Risk stratification guides personalized treatment and TSH suppression therapy decisions.
- Tyrosine kinase inhibitors offer new options for inoperable and radioiodine-refractory DTC.
Conclusions:
- Optimal management of differentiated thyroid carcinoma involves individualized treatment strategies.
- Advancements in therapy, including novel agents, have further improved outcomes for DTC patients.
- Risk stratification is essential for tailoring treatment and follow-up plans.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...